Radio and PodcastRadio and PodcastLive Radio & Podcasts
Tisotumab Vedotin in Second- & Third-Line Recurrent Cervical Cancer with Dr. Ignace Vergote artwork
Science & Medicine

Tisotumab Vedotin in Second- & Third-Line Recurrent Cervical Cancer with Dr. Ignace Vergote

IJGC Podcast by BMJ Group

Oct 7, 202426:16Science & Medicine

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Ignace Vergote to discuss Tisotumab Vedotin in Second- & Third-Line Recurrent Cervical Cancer. Prof. Vergote was Chairman of the Dep...

About This Episode

Tisotumab Vedotin in Second- & Third-Line Recurrent Cervical Cancer with Dr. Ignace Vergote is an episode from IJGC Podcast by BMJ Group. In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Ignace Vergote...

Podcast

This episode belongs to IJGC Podcast.

Listen Online

Use the player on this page to stream the episode online.

Episode Details

Published Oct 7, 2024, 26:16 long, audio available.